Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Colistin for VAP Prevention
NCT04208945Unknown
- Sponsor
- University of Thessaly
- Start
- Dec 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of colistimethate sodium in ventilator-associated pneumonia (VAP) (2 arms), sponsored by University of Thessaly. Primary endpoint: Incidence of Gram Negative Bacterial Ventilator-Associated Pneumonia at 28 days. Status: unknown.
02
Drugs
colistimethate sodium
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT04208945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04208945.